EGFR and lung cancer: 31228622 31228622 Offin M, Chan JM, Tenet M et al (2019) Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.